These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16757533)

  • 41. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.
    Salvatore G; Giannini R; Faviana P; Caleo A; Migliaccio I; Fagin JA; Nikiforov YE; Troncone G; Palombini L; Basolo F; Santoro M
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5175-80. PubMed ID: 15472223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
    Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA
    Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Real-time quantitative analysis of E-cadherin expression in ret/PTC-1-activated thyroid neoplasms.
    Smyth P; Sheils O; Finn S; Martin C; O'Leary J; Sweeney EC
    Int J Surg Pathol; 2001 Oct; 9(4):265-72. PubMed ID: 12574841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RET oncogene expression of papillary thyroid carcinoma in Korea.
    Chung KW; Chang MC; Noh DY; Oh SK; Choe KJ; Youn YK
    Surg Today; 2004; 34(6):485-92. PubMed ID: 15170542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RET/PTC rearrangements in Hashimoto's thyroiditis.
    Sheils O; Smyth P; Finn S; Sweeney EC; O'Leary JJ
    Int J Surg Pathol; 2002 Apr; 10(2):167-8; author reply 168-9. PubMed ID: 12075413
    [No Abstract]   [Full Text] [Related]  

  • 46. Genetic events in the evolution of thyroid cancer.
    Freeman J; Carroll C; Asa S; Ezzat S
    J Otolaryngol; 2002 Aug; 31(4):202-6. PubMed ID: 12240753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Gene rearrangement studies in Hashimoto's thyroiditis and primary lymphoma of thyroid].
    Huo Z; Li Y; Zhong DR; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):344-7. PubMed ID: 16834908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma.
    Raouane M; Desmaele D; Gilbert-Sirieix M; Gueutin C; Zouhiri F; Bourgaux C; Lepeltier E; Gref R; Ben Salah R; Clayman G; Massaad-Massade L; Couvreur P
    J Med Chem; 2011 Jun; 54(12):4067-76. PubMed ID: 21561161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ret/PTC-1 expression alters the immunoprofile of thyroid follicular cells.
    Denning K; Smyth P; Cahill S; Li J; Flavin R; Aherne S; O' Leary JJ; Sheils O
    Mol Cancer; 2008 May; 7():44. PubMed ID: 18505566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary thyroid high-grade B-cell lymphoma with MYC and BCL2 rearrangements in Hashimoto's thyroiditis.
    Tariq H; Zahra U
    Diagn Cytopathol; 2022 Feb; 50(2):84-85. PubMed ID: 34962105
    [No Abstract]   [Full Text] [Related]  

  • 51. Values of molecular markers in the differential diagnosis of thyroid abnormalities.
    Tennakoon TMPB; Rushdhi M; Ranasinghe ADCU; Dassanayake RS
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):913-931. PubMed ID: 28008451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RET/PTC fusion gene products in patients suffering from thyroid carcinomas.
    Bachrati CZ; Pocsai G; Raskó I
    Laryngoscope; 1999 Jun; 109(6):1011-5. PubMed ID: 10369300
    [No Abstract]   [Full Text] [Related]  

  • 53. DISTRIBUTION OF STEM CELLS IN DIFFERENT THYROID LESIONS IN PATIENTS OF REPRODUCTIVE, MENOPAUSAL AND POST-MENOPAUSAL AGE.
    Muzashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2021 Mar; (312):92-99. PubMed ID: 33964835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid intrafollicular neoplasia: a spectrum of morphological appearances from benign cytologic precursors to microscopic papillary carcinoma.
    Pennelli N
    J Postgrad Med; 2007; 53(1):5-6. PubMed ID: 17244961
    [No Abstract]   [Full Text] [Related]  

  • 55. Hashimoto's disease and carcinoma of the thyroid.
    LERRICK A
    Conn Med; 1962 Nov; 26():639-41. PubMed ID: 13929861
    [No Abstract]   [Full Text] [Related]  

  • 56. Carcinoma of the thyroid with Ewing/PNET family tumor elements: a tumor of unknown histogenesis.
    Eloy C; Cameselle-Teijeiro J; Vieira J; Teixeira MR; Cruz J; Sobrinho-Simões M
    Int J Surg Pathol; 2014 Sep; 22(6):579-81. PubMed ID: 23637257
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of chicken models for the analysis of human disease.
    Dodgson JB; Romanov MN
    Curr Protoc Hum Genet; 2004 May; Chapter 15():Unit 15.5. PubMed ID: 18428358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indicators of multifocality in papillary thyroid carcinoma concurrent with Hashimoto's thyroiditis.
    Dong S; Xie XJ; Xia Q; Wu YJ
    Am J Cancer Res; 2019; 9(8):1786-1795. PubMed ID: 31497359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma.
    Uhliarova B; Hajtman A
    Braz J Otorhinolaryngol; 2018; 84(6):729-735. PubMed ID: 28964693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?
    Jankovic B; Le KT; Hershman JM
    J Clin Endocrinol Metab; 2013 Feb; 98(2):474-82. PubMed ID: 23293329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.